INTERNATIONAL PATENT: JOSLIN DIABETES CENTER FILES APPLICATION FOR "ACTIVATION OR INHIBITION OF GLP-1 PATHWAYS"

GENEVA, Nov. 5 -- JOSLIN DIABETES CENTER (One Joslin PlaceBoston, Massachusetts 02215) filed a patent application (PCT/US2025/025622) for "ACTIVATION OR INHIBITION OF GLP-1 PATHWAYS" on Apr 21, 2025. With publication no. WO/2025/226602, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BLACKWELL, T. Keith (c/o Joslin Diabetes CenterOne Joslin PlaceBoston, Massachusetts 02215), ZHU, Feimei (c/o Joslin Diabetes CenterOne Joslin PlaceBoston, Massachusetts 02215), KAHN, C. Ronald (c/o Joslin Diabetes CenterOne Joslin PlaceBosto...